Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A, Miszewski K, Gager Y, Koch S, Pötschke J, Ugrinovski D, Gabert J, Pospieszyńska A, Wydra D, Duchnowska R, Szymanowski B, Cierniak S, Kruecken I, Neumann K, Mirkov K, Biernat W, Czapiewski P.
Gorczyński A, et al.
Cancer Biomark. 2023;38(1):17-26. doi: 10.3233/CBM-230117.
Cancer Biomark. 2023.
PMID: 37522200